¼¼°èÀÇ ¾×ü »ê¼Ò ÀåÄ¡ ½ÃÀå
Liquid Oxygen Devices
»óǰÄÚµå : 1791705
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,257,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,771,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¾×ü »ê¼Ò ÀåÄ¡ ½ÃÀåÀº 2030³â±îÁö 138¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 114¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¾×ü »ê¼Ò ÀåÄ¡ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 3.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 138¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ º´¿øÀº CAGR 3.8%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 86¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿Ü·¡ ȯÀÚ ½Ã¼³ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 2.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 31¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¾×ü »ê¼Ò ÀåÄ¡ ½ÃÀåÀº 2024³â¿¡ 31¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 28¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 6.3%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 1.3%¿Í 2.6%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.9%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¾×ü »ê¼Ò ÀåÄ¡ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¾×ü »ê¼Ò ÀåÄ¡°¡ ÇコÄɾ¼­ Á¡Á¡ ´õ Áß¿äÇØÁö´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¾×ü »ê¼Ò ÀåÄ¡´Â È£Èí±â ÁúȯÀ̳ª ½É°¢ÇÑ ÀÇ·áÀû Çʿ並 °¡Áø ȯÀÚ¸¦ Áö¿øÇÏ´Â Çö´ë ÀÇ·áÀÇ Çʼö ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ¾ÐÃà °¡½º »ê¼Ò ½Ç¸°´õ¿Í ´Þ¸® ¾×ü »ê¼Ò ÀåÄ¡´Â È޴뼺, È¿À²¼º, Àå±â »ê¼Ò ÀúÀ强ÀÌ ¿ì¼öÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ÀçÅà »ê¼Ò ¿ä¹ý, º´¿ø, ÀÀ±Þ ÀÇ·á ¼­ºñ½º¿¡ ³Î¸® »ç¿ëµÇ¾î ÀÇ·á µî±ÞÀÇ ½Å·ÚÇÒ ¼ö ÀÖ´Â »ê¼Ò °ø±Þ¿øÀ» Á¦°øÇÕ´Ï´Ù. ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), õ½Ä ¹× ±âŸ È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ¾×ü »ê¼Ò ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °í·ÉÈ­°¡ ÁøÇàµÇ°í Æó ÁúȯÀÇ ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ½Ã½ºÅÛÀº ȯÀÚÀÇ Ä¡·á¿Í À̵¿¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ¾×ü »ê¼Ò ¼Ö·ç¼ÇÀ» ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾×ü »ê¼Ò ÀåÄ¡´Â ±âÁ¸ ¹æ½Ä¿¡ ºñÇØ ´õ ³ôÀº ¼øµµ ¼öÁذú Áö¼ÓÀûÀÎ »ê¼Ò °ø±ÞÀ» º¸ÀåÇϱ⠶§¹®¿¡ ÁßÁõ ȯÀÚ¿¡°Ô ÀÌ»óÀûÀÎ Á¦Ç°ÀÔ´Ï´Ù. ÀçÅÃÄ¡·á ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀº ȯÀÚ°¡ Æí¸®ÇÏ°í »ç¿ëÇϱ⠽±°í °¡º­¿î »ê¼Ò °ø±Þ ½Ã½ºÅÛÀ» ¿øÇϱ⠶§¹®¿¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ±â¼ú°ú »ê¼Ò Ä¡·á ¼Ö·ç¼ÇÀÇ ¹ßÀüÀ¸·Î ¾×ü »ê¼Ò ÀåÄ¡´Â ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» °è¼ÓÇϰí ÀÖ½À´Ï´Ù.

¾×ü »ê¼Ò ÀåÄ¡ÀÇ Ãֽбâ¼ú ¹ßÀüÀº ¹«¾ùÀΰ¡?

±â¼úÀÇ ¹ßÀüÀ¸·Î ¾×ü »ê¼Ò ÀåÄ¡ÀÇ µðÀÚÀÎ, ±â´É¼º, È¿À²¼ºÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. °¡Àå ÁÖ¸ñÇÒ ¸¸ÇÑ °³¹ß Áß Çϳª´Â ÀÚÁÖ »ê¼Ò¸¦ º¸ÃæÇÏÁö ¾Ê°íµµ Àå½Ã°£ »ê¼Ò¸¦ °ø±ÞÇÒ ¼ö ÀÖ´Â ÄÄÆÑÆ®ÇÏ°í °¡º­¿î ½Ã½ºÅÛÀ» ÅëÇÕÇÑ °ÍÀÔ´Ï´Ù. ÈÞ´ë¿ë ¾×ü »ê¼Ò ³óÃà±â´Â ÀçÅà »ê¼Ò ¿ä¹ý¿¡ Çõ¸íÀ» °¡Á®¿ÔÀ¸¸ç, ȯÀÚµéÀº ºÎÇǰ¡ Å« Àåºñ¿¡ ¾ô¸ÅÀÌÁö ¾Ê°íµµ Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» À¯ÁöÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ½º¸¶Æ® ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÌ ¾×ü »ê¼Ò ÀåÄ¡¿¡ ³»ÀåµÇ¾î »ê¼Ò ³óµµ, ±â±â ¼º´É, ȯÀÚÀÇ »ç¿ë ÆÐÅÏÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ȯÀÚ¸¦ ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇϰí Àû½Ã¿¡ °³ÀÔÇÏ¸ç »ê¼Ò ¿ä¹ýÀÇ ¼øÀÀµµ¸¦ Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ÁÖ¿ä ¹ßÀüÀº »ê¼Ò Áõ¹ßÀ» ÃÖ¼ÒÈ­ÇÏ°í ¼ö¸íÀ» ¿¬ÀåÇÏ´Â °íÈ¿À² Àú¿Â ÀúÀå ÅÊÅ©ÀÇ °³¹ßÀÔ´Ï´Ù. Áö¼Ó °¡´ÉÇϰí ȯ°æ ģȭÀûÀÎ µðÀÚÀεµ µîÀåÇϰí ÀÖÀ¸¸ç, Á¦Á¶¾÷üµéÀº ÀçȰ¿ë °¡´ÉÇÑ Àç·á¿Í ¿¡³ÊÁö È¿À²ÀûÀÎ ¾×ü »ê¼Ò ½Ã½ºÅÛ¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ¶ÇÇÑ, ¿þ¾î·¯ºí ±â±â ¹× ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ǰúÀÇ ±â¼ú ÅëÇÕÀ» ÅëÇØ »ê¼Ò ¿ä¹ýÀ» °£¼ÒÈ­Çϰí ȯÀÚ¿¡°Ô °³ÀÎÈ­µÈ ÅëÂû·Â°ú ÀÚµ¿È­µÈ ¾Ë¸²À» Á¦°øÇÕ´Ï´Ù. »ç¿ëÀÚ Ä£È­ÀûÀ̰í Áö´ÉÀûÀÎ »ê¼Ò °ø±Þ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Á¦Á¶¾÷üµéÀº ¾ÈÀü¼º, ½Å·Ú¼º, Á¢±Ù¼ºÀ» ³ôÀ̱â À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

¼ÒºñÀÚ ¼ö¿ä´Â ¾î¶»°Ô ¾×ü »ê¼Ò ÀåÄ¡ ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

È£Èí±â °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¸¸¼º Æó ÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾×ü »ê¼Ò ÀåÄ¡¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ȯÀÚ¿Í °£º´ÀÎÀº À̵¿¼º°ú µ¶¸³¼ºÀ» ³ô¿©ÁÖ´Â ÀÛ°í °¡º±°í »ç¿ëÇϱ⠽¬¿î ¼Ö·ç¼ÇÀ» Àû±ØÀûÀ¸·Î ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ÀçÅà »ê¼Ò Ä¡·áÀÇ Ãß¼¼´Â ±âÁ¸ ½Ç¸°´õ½Ä ½Ã½ºÅÛ¿¡ ºñÇØ Àå½Ã°£ »ê¼Ò °ø±Þ°ú ÆíÀǼºÀ» Á¦°øÇÏ´Â ÈÞ´ë¿ë ¹× ¸®ÇÊÇü ¾×ü »ê¼Ò ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä ±ÞÁõÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñħ½ÀÀû È£Èí Áö¿ø¿¡ ´ëÇÑ ¼±È£´Â ¾×ü »ê¼Ò ±â¼úÀÇ Çõ½ÅÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, Á¦Á¶¾÷ü´Â Á¶¿ëÇϰí È¿À²ÀûÀÌ¸ç »ç¿ëÀÚ Á¤ÀÇ °¡´ÉÇÑ °ø±Þ ½Ã½ºÅÛ¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. Äڷγª19 »çÅ·ΠÀÎÇØ »ê¼Ò ¿ä¹ý¿¡ ´ëÇÑ ÀνÄÀÌ ´õ¿í ³ô¾ÆÁ³°í, ÀÇ·á¿ë »ê¼Ò ÀÎÇÁ¶ó ¹× »ý»ê¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çß½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ½Ç½Ã°£ »ê¼Ò ÃßÀû ¹× ȯÀÚ °ü¸®¿¡ ÁßÁ¡À» µÎ¸é¼­ ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ È®´ëµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ê¼Ò Ä¡·á ÀåºñÀÇ Àú·ÅÇÑ °¡°Ý°ú º¸Çè Àû¿ëÀÌ ±¸¸Å °áÁ¤¿¡ Áß¿äÇÑ ¿ªÇÒÀ»Çϰí ÀÖÀ¸¸ç, ¸¹Àº ȯÀÚµéÀÌ ºñ¿ë È¿À²ÀûÀ̰í Àå±âÀûÀÎ ¾×ü »ê¼Ò ¼Ö·ç¼ÇÀ» ¼±ÅÃÇϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ ±â´ë°¡ ÁøÈ­ÇÔ¿¡ µû¶ó, ±â¾÷µéÀº ¾×ü »ê¼Ò ÀåÄ¡ÀÇ »ç¿ë ÆíÀǼº, È޴뼺, ½º¸¶Æ®ÇÑ ¿¬°á¼ºÀ» ¿ì¼±¼øÀ§¿¡ µÎ°í ȯÀÚÀÇ ÃÖÀûÀÇ °æÇè°ú ó¹æµÈ Ä¡·á¹ýÀ» ÁؼöÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

¾×ü »ê¼Ò ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

¾×ü »ê¼Ò ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀº »ê¼Ò Ä¡·á ±â¼úÀÇ ¹ßÀü, È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀçÅÃÄ¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ¸¸¼º ÆóÁúȯ, ƯÈ÷ Àå±âÀûÀÎ »ê¼Ò ¿ä¹ýÀ» ÇÊ¿ä·Î ÇÏ´Â COPD¿Í õ½ÄÀÇ ±ÞÁõÀÔ´Ï´Ù. ³ëÀÎÀº È£Èí±â Áúȯ¿¡ °É¸®±â ½±°í È¿À²ÀûÀÎ »ê¼Ò °ø±Þ ½Ã½ºÅÛ¿¡ ÀÇÁ¸Çϱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ÈÞ´ë¿ë ¾×ü »ê¼Ò ÀåÄ¡ÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ȯÀÚ°¡ À̵¿¼º°ú µ¶¸³¼ºÀ» À¯ÁöÇÒ ¼ö ÀÖ°Ô µÇ¾î ½ÃÀå ±âȸ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÇコÄÉ¾î »ê¾÷ÀÇ ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µÀ¸·ÎÀÇ ÀüȯÀº ¾×ü »ê¼Ò ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÆÒµ¥¹ÍÀ¸·Î ÀÎÇÑ »ê¼Ò ºÎÁ·À¸·Î ÀÎÇØ Á¤ºÎ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â °­·ÂÇÑ »ê¼Ò ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ¸¦ Àå·ÁÇÏ°í ¾×ü »ê¼Ò ½Ã½ºÅÛÀÇ »ý»ê ¹× À¯ÅëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ØÀú¿Â ÀúÀå ¹× ÀÚµ¿ »ê¼Ò °ø±Þ ¸ÞÄ¿´ÏÁòÀÇ ±â¼úÀû Áøº¸·Î ÀÎÇØ ÀåºñÀÇ È¿À²¼ºÀÌ Çâ»óµÇ°í »ê¼Ò ³¶ºñ¸¦ ÃÖ¼ÒÈ­ÇÏ¿© ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ãŵ´Ï´Ù. »ê¼Ò Ä¡·á Àåºñ¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú À¯¸®ÇÑ »óȯ Á¤Ã¥Àº °è¼ÓÇØ¼­ ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, ¾×ü »ê¼Ò ÀåÄ¡¸¦ ´õ ¸¹Àº ȯÀÚÃþÀÌ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. È£Èí±â °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¾×ü »ê¼Ò ÀåÄ¡ ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î È®´ëµÇ°í ÀÖÀ¸¸ç, ÁøÈ­ÇÏ´Â ÇコÄɾ ´ëÀÀÇϰí Àü ¼¼°è ȯÀÚ °á°ú¸¦ °³¼±ÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

ºÎ¹®

ÃÖÁ¾ »ç¿ë(º´¿ø, ¿Ü·¡ ȯÀÚ ½Ã¼³, ȨÄɾî)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°è °íÀ¯ SLM¿¡ Äõ¸®-ÇÏ´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Liquid Oxygen Devices Market to Reach US$13.8 Billion by 2030

The global market for Liquid Oxygen Devices estimated at US$11.4 Billion in the year 2024, is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Outpatient Facilities segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 6.3% CAGR

The Liquid Oxygen Devices market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Liquid Oxygen Devices Market - Key Trends & Drivers Summarized

Why Are Liquid Oxygen Devices Gaining Importance in Healthcare?

Liquid oxygen devices have become an essential component in modern healthcare, supporting patients with respiratory conditions and critical medical needs. Unlike traditional compressed gas oxygen cylinders, liquid oxygen devices offer greater portability, efficiency, and long-term oxygen storage. These systems are widely used for home-based oxygen therapy, hospitals, and emergency medical services, providing a reliable source of medical-grade oxygen. The increasing prevalence of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory illnesses has significantly boosted demand for liquid oxygen devices. With a growing aging population and the rising incidence of pulmonary diseases, healthcare systems are integrating liquid oxygen solutions to enhance patient care and mobility. Additionally, liquid oxygen devices ensure a higher purity level and a continuous oxygen supply compared to conventional methods, making them ideal for critical care patients. The shift toward home healthcare solutions has further accelerated market growth, as patients seek convenient, lightweight, and easy-to-use oxygen delivery systems. With advancements in medical technology and oxygen therapy solutions, liquid oxygen devices continue to play a vital role in improving patient outcomes and enhancing quality of life.

What Are the Latest Technological Advancements in Liquid Oxygen Devices?

Technological advancements have significantly improved the design, functionality, and efficiency of liquid oxygen devices. One of the most notable developments is the integration of compact, lightweight systems that provide extended oxygen supply without frequent refills. Portable liquid oxygen concentrators have revolutionized home oxygen therapy, enabling patients to maintain an active lifestyle without being tethered to bulky equipment. Additionally, smart monitoring systems are being incorporated into liquid oxygen devices, allowing real-time tracking of oxygen levels, device performance, and patient usage patterns. These innovations help healthcare providers monitor patients remotely, ensuring timely intervention and improved adherence to oxygen therapy. Another key advancement is the development of high-efficiency cryogenic storage tanks that minimize oxygen evaporation and enhance longevity. Sustainable and eco-friendly designs are also emerging, with manufacturers focusing on recyclable materials and energy-efficient liquid oxygen systems. Moreover, technological integration with wearable devices and mobile applications is streamlining oxygen therapy, offering patients personalized insights and automated alerts. As the demand for user-friendly and intelligent oxygen delivery solutions increases, manufacturers are investing in research and development to enhance safety, reliability, and accessibility in liquid oxygen devices.

How Is Consumer Demand Shaping the Liquid Oxygen Devices Market?

The increasing awareness of respiratory health, coupled with the rising burden of chronic lung diseases, has significantly influenced consumer demand for liquid oxygen devices. Patients and caregivers are actively seeking compact, lightweight, and user-friendly solutions that enable greater mobility and independence. The trend toward home-based oxygen therapy has led to a surge in demand for portable and refillable liquid oxygen units, as they offer prolonged oxygen supply and convenience compared to traditional cylinder-based systems. Additionally, the preference for non-invasive respiratory support is driving innovation in liquid oxygen technology, with manufacturers focusing on silent, efficient, and customizable delivery systems. The COVID-19 pandemic has further heightened awareness of oxygen therapy, leading to increased investments in medical oxygen infrastructure and production. The expansion of telehealth and remote patient monitoring has also contributed to market growth, as healthcare providers emphasize real-time oxygen tracking and patient management. Furthermore, affordability and insurance coverage for oxygen therapy equipment play a crucial role in purchasing decisions, with many patients opting for cost-effective, long-term liquid oxygen solutions. As consumer expectations evolve, companies are prioritizing ease of use, portability, and smart connectivity in liquid oxygen devices, ensuring optimal patient experience and compliance with prescribed therapy.

What Are the Primary Growth Drivers of the Liquid Oxygen Devices Market?

The growth in the liquid oxygen devices market is driven by several factors, including advancements in oxygen therapy technology, the increasing prevalence of respiratory disorders, and the rising demand for home healthcare solutions. One of the key growth drivers is the surge in chronic lung disease cases, particularly COPD and asthma, which require long-term oxygen therapy. The aging global population is another critical factor, as elderly individuals are more susceptible to respiratory conditions and rely on efficient oxygen delivery systems. Additionally, the increasing adoption of portable liquid oxygen devices has expanded market opportunities, allowing patients to maintain mobility and independence. The healthcare industry's shift toward telemedicine and remote monitoring has further fueled demand for liquid oxygen devices, as real-time tracking enhances patient management and adherence to treatment plans. The pandemic-induced oxygen shortages have also prompted governments and healthcare providers to invest in robust oxygen infrastructure, boosting the production and distribution of liquid oxygen systems. Moreover, technological advancements in cryogenic storage and automated oxygen delivery mechanisms have improved device efficiency, minimizing oxygen waste and enhancing patient comfort. Regulatory support and favorable reimbursement policies for oxygen therapy equipment continue to influence market dynamics, making liquid oxygen devices more accessible to a broader patient base. As the emphasis on respiratory health grows, the liquid oxygen devices market is poised for sustained expansion, catering to the evolving healthcare landscape and improving patient outcomes worldwide.

SCOPE OF STUDY:

The report analyzes the Liquid Oxygen Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Outpatient Facilities, Home Care)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â